OGA and Hyperglycemia: They showed that hyperglycemia reduced both mRNA level and promoter activity of SERCA2a in isolated cardiomyocytes and that the effect of hyperglycemia on SERCA2a was attenuated by overexpression of O-GlcNAcase and mimicked by overexpression of O-GlcNAc-transferase.